
	As previously
	reported		Adjustment		As restated
Balance Sheet as of October 14, 2020
Warrant derivative liability	$	—	$	28,030,000	$	28,030,000
Total liabilities		19,092,923		28,030,000		47,122,923
Class A common stock subject to possible redemption		477,874,167		(28,030,000)		449,844,167
Class A commmon stock		221		281		502
Additional paid-in capital		5,002,872		1,045,834		6,048,706
Accumulated deficit		(2,451)		(1,046,115)		(1,048,566)

Balance Sheet as of December 31, 2020
Warrant derivative liability	$	—	$	55,720,000	$	55,720,000
Total liabilities		17,627,450		55,720,000		73,347,450
Class A common stock subject to possible redemption		478,574,408		(55,720,000)		422,854,408
Class A commmon stock		215		557		772
Additional paid-in capital		5,152,825		28,735,558		33,888,383
Accumulated deficit		(154,280)		(28,736,115)		(28,890,395)

Statement of Operations as of December 31, 2020
General and administrative expenses	$	(232,904)	$	(1,046,115)	$	(1,279,019)
Change in fair value of warrant derivative liability		—		(27,690,000)		(27,690,000)
Total other income (expense)		78,624		(27,690,000)		(27,611,376)
Net loss		(154,280)		(28,736,115)		(28,890,395)
Basic and diluted loss per share		(0.02)		(2.97)		(2.99)

Statement of Cash Flows as of December 31, 2020
Net loss	$	(154,280)	$	(28,736,115)	$	(28,890,395)
Change in fair value of warrant derivative liability		—		(27,690,000)		(27,690,000)
Net cash used in operating activities		(211,292)		(1,046,115)		(1,257,407)
Payment for underwriting discounts		(10,000,000)		1,046,115		(8,953,885)
Net cash provided by financing activites		501,228,698		1,046,115		502,274,813

Consolidated Statement of Comprehensive Loss

Amounts in thousands (except per share amounts)


	Year Ended December 28, 2019						Year Ended December 29, 2018
	As		Restatement		As			As	Restatement		As
	Reported		Adjustments		Restated			Reported	Adjustments		Restated
Income tax (benefit) expense	$	(5,370)	$	(17,907)	$	(23,277)	$	2,070	$	(10,960)	$	(8,890)
Net loss		(103,386)		17,907		(85,479)		(69,641)		10,960		(58,681)
Comprehensive loss		(97,836)		17,907		(79,929)		(80,694)		10,960		(69,734)
Basic and diluted loss per share		(191)		33		(158)		(128)		20		(108)

Consolidated Balance Sheets


	Year Ended December 28, 2019						Year Ended December 29, 2018
	As		Restatement		As		As		Restatement		As
	Reported		Adjustments		Restated		Reported		Adjustments		Restated
Goodwill(1)	$	819,077	$	(3,227)	$	815,850	$	803,847	$	(3,227)	$	800,620
Total Assets		2,441,210		(3,227)		2,437,983		2,431,470		(3,227)		2,428,243
Deferred tax liabilities		196,437		(32,094)		164,343		200,696		(14,187)		186,509
Total liabilities		2,096,108		(32,094)		2,064,014		1,992,363		(14,187)		1,978,176
Accumulated deficit		(176,217)		28,867		(147,350)		(72,831)		10,960		(61,871)
Total stockholder’s equity		345,102		28,867		373,969		439,107		10,960		450,067
Total liabilities and stockholder’s equity		2,441,210		(3,227)		2,437,983		2,431,470		(3,227)		2,428,243

(1)

The Company incorrectly established a valuation allowance on deferred taxes related to the interest limitations from the MinuteKey and Big Time Products acquisitions in 2018 during purchase accounting through goodwill. The correction of the error resulted in a reduction of goodwill of $1,160 for MinuteKey and $2,067 for Big Time Products.

Consolidated Statements of Cash Flows


	Year Ended December 28, 2019						Year Ended December 29, 2018
	As		Restatement		As		As		Restatement		As
	Reported		Adjustments		Restated		Reported		Adjustments		Restated
Cash flows from operating activities:
Net loss	$	(103,386)	$	17,907	$	(85,479)	$	(69,641)	$	10,960	$	(58,681)
Deferred income taxes		(5,679)		(17,907)		(23,586)		394		(10,960)		(10,566)
Net cash provided by operating activities	$	52,359	$	—	$	52,359	$	7,547	$	—	$	7,547